Phase 3 Clinical Trial Results on J&J’s COVID-19 Vaccine to Be Released Soon
Dimensions of Dental Hygiene
JANUARY 11, 2021
Johnson & Johnson (J&J) may publish data from its COVID-19 vaccine’s Phase 3 clinical trial as early as the end of January. If the results demonstrate the vaccine’s safety and efficacy, it could receive Emergency Use Authorization (EUA) from the United States Food and Drug Administration by February.
98 
Let's personalize your content